⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 25, 2021Expert Review of VaccinesOpen Access

The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?

Md Kamal Hossain Majid Hassanzadeganroudsari Vasso Apostolopoulos

View Full Paper

Ask AI

Bookmark

Share

Abstract

A novel strain of coronavirus, SARS-CoV-2, the causative agent of coronavirus disease (COVID-19) was first associated with severe acute respiratory disease in late 2019 and has triggered an ongo...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hossain et al. (2021) studied this question.

synapsesocial.com/papers/6aaf3f1bb2a1ff4234110055 https://doi.org/10.1080/14760584.2021.1915140

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Surveillance is underestimating the burden of the COVID-19 pandemicOriginal Research · 2020 · 91 citations
2Covid-19: New coronavirus variant is identified in UKOriginal Research · 2020 · 347 citations
3SARS-CoV-2: vaccines in the pandemic eraReview · 2021 · 64 citations
4Safety and immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy Chinese adults: two single-center, randomized, double-blind Phase 1 and Phase 2 trialsExpert Review of Vaccines · Thu,
5The socioeconomic value of adult respiratory vaccination in Australia: a benefit-cost analysisExpert Review of Vaccines · Sat,

More from Expert Review of Vaccines

Virus-like particle vaccines: from antigen architecture to antigen presentation and adaptive immune responsesWed,
Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in GermanyMon,
Differing influenza vaccine uptake and recommendation behavior among healthcare workers in primary health centers, secondary and tertiary hospitals, and schools in a metropolis of southern ChinaWed,
Global policy determinants of national human papillomavirus vaccine introductions in 2006–2025Tue,
Global vaccine readiness: equity-by-design in pandemic preparedness and responseWed,